Sugi Predict

Sugi Predict / Compounds / SCHEMBL20048853

SCHEMBL20048853

SCHEMBL20048853

CO[S@@](=O)c1cccc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ RELA Q04206 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ TSHR P16473 1/20 0.35
▸ PARP1 P09874 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ PGR P06401 1/20 0.34
▸ SLC6A3 Q01959 2/20 0.33
▸ XPO1 O14980 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MGLL Q99685 1/20 0.33
▸ NOTUM Q6P988 1/20 0.33
▸ MPO P05164 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21691220 1.00 CYP1A2 (0.39) CYP1A2CYP3A4CYP2C19RELAALDH1A1
SCHEMBL17024062 0.79 TSHR (0.38) CYP3A4ALDH1A1TSHRMEN1MAPT
SCHEMBL19139964 0.78 ACHE (0.44) RELAALDH1A1TSHRPARP1TDP1
SCHEMBL15959324 0.77 CYP2A6 (0.42) ALDH1A1NPC1RAB9AMEN1MAPT
SCHEMBL949226 0.76 ALDH1A1 (0.40) CYP1A2ALDH1A1TSHRPARP1NPC1
SCHEMBL14305114 0.74 ALDH1A1 (0.38) ALDH1A1SLC6A3RAB9AMEN1LMNA
SCHEMBL21691195 0.73 TSHR (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1TSHR
SCHEMBL20048857 0.73 TSHR (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1TSHR
SCHEMBL30306598 0.73 TSHR (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1TSHR
SCHEMBL950283 0.73 TSHR (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11802110-B2 2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase Oxford Drug Design Limited (GB) 2023-10-31 — — US disclosed
US-11802110-B2 2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase Oxford Drug Design Limited (GB) 2023-10-31 — — US disclosed
US-20200039929-A1 2-AMINO-N-(ARYLSULFINYL)-ACETAMIDE COMPOUNDS AS INHIBITORS OF BACTERIAL AMINOACYL-TRNA SYNTHETASE INHIBOX LIMITED (GB) 2020-02-06 — — US disclosed
WO-2018065611-A1 2-AMINO-N-(ARYLSULFINYL)-ACETAMIDE COMPOUNDS AS INHIBITORS OF BACTERIAL AMINOACYL-TRNA SYNTHETASE Oxford Drug Design Limited (GB) 2018-04-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11802110-B2 2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase AARS1, NSUN3, GARS1 CYP1A2 3524/4885CYP3A4 4494/4885CYP2C19 4645/4885
US-20200039929-A1 2-AMINO-N-(ARYLSULFINYL)-ACETAMIDE COMPOUNDS AS INHIBITORS OF BACTERIAL AMINOACYL-TRNA SYNTHETASE AARS1, NSUN3, GARS1 CYP1A2 3524/4885CYP3A4 4494/4885CYP2C19 4645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.